Skip to main content
Caplight Logo









TheraPPI Bioscience

TheraPPI Bioscience

Private
LyonHealthcare & Life Scienceshttps://tppibio.com/

Last Round

Debt

Dec 18, 2025

Total Funding Raised

$490,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

TheraPPI Bioscience is a biotechnology company that develops small molecule drugs targeting protein-protein interactions to treat cancer, rare diseases, and inflammatory conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

small-molecule drugsprotein-protein interactionsPPIRAS-MAPK pathwayoncology drug developmentdrug resistancepreclinical biotechrare disease therapeuticsdrug discoverymedicinal chemistrybiotech licensingtranslational biologypharma partneringdrug pipelinewet-lab research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TheraPPI Bioscience Comparables

Compare TheraPPI Bioscience with similar companies based on industry and business-model similarity.

TheraPPI Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Johnson & Johnson
79%
Balto Pharmaceuticals
77%
Step Pharma
76%

TheraPPI Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtDec 18, 2025
Pre SeedFeb 9, 2025
GrantFeb 5, 2024
SeedNov 16, 2023

Key People

Founding team and executive leadership

Luc Otten

Chief Executive Officer And Founder

Founding Team

TheraPPI Bioscience Investors

Notable investors and investment history

TheraPPI Bioscience investors
InvestorRounds
FongitSeed, Pre Seed
PulsalysPre Seed
BpifranceDebt, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 18, 2025

    $300K round with Bpifrance

  • Feb 9, 2025

    Secured funding from Fongit and Pulsalys.

TheraPPI Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TheraPPI Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TheraPPI Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersLyon
Employee Range6
Year Founded2023
Last FundingDec 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?